Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.

Also called NCT06153433

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 112 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06153433
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06153433. Randomized; no masking; primary purpose treatment. Start 2023-11-06 (actual); primary completion 2024-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
Condition
Dyslipidemia
Intervention (Drug)
Rosuvastatin Immediate-Release Tablet (IRT) 10mg
Intervention (Drug)
Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct06153433
Content hash
de004041c0992297c1ffaa756e6bafa826b9f710363f886f8f8cb9b57bba3d55